1. Home
  2. SPRC vs RELI Comparison

SPRC vs RELI Comparison

Compare SPRC & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • RELI
  • Stock Information
  • Founded
  • SPRC 2004
  • RELI 2013
  • Country
  • SPRC Israel
  • RELI United States
  • Employees
  • SPRC N/A
  • RELI N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • RELI Specialty Insurers
  • Sector
  • SPRC Health Care
  • RELI Finance
  • Exchange
  • SPRC Nasdaq
  • RELI Nasdaq
  • Market Cap
  • SPRC 3.5M
  • RELI 3.4M
  • IPO Year
  • SPRC N/A
  • RELI N/A
  • Fundamental
  • Price
  • SPRC $0.28
  • RELI $1.25
  • Analyst Decision
  • SPRC
  • RELI
  • Analyst Count
  • SPRC 0
  • RELI 0
  • Target Price
  • SPRC N/A
  • RELI N/A
  • AVG Volume (30 Days)
  • SPRC 161.2K
  • RELI 40.9K
  • Earning Date
  • SPRC 02-15-2025
  • RELI 05-19-2025
  • Dividend Yield
  • SPRC N/A
  • RELI N/A
  • EPS Growth
  • SPRC N/A
  • RELI N/A
  • EPS
  • SPRC N/A
  • RELI N/A
  • Revenue
  • SPRC $1,747,000.00
  • RELI $14,054,361.00
  • Revenue This Year
  • SPRC N/A
  • RELI N/A
  • Revenue Next Year
  • SPRC N/A
  • RELI N/A
  • P/E Ratio
  • SPRC N/A
  • RELI N/A
  • Revenue Growth
  • SPRC N/A
  • RELI 2.35
  • 52 Week Low
  • SPRC $0.20
  • RELI $0.97
  • 52 Week High
  • SPRC $1.79
  • RELI $18.53
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 54.30
  • RELI 40.76
  • Support Level
  • SPRC $0.25
  • RELI $0.97
  • Resistance Level
  • SPRC $0.31
  • RELI $1.06
  • Average True Range (ATR)
  • SPRC 0.02
  • RELI 0.06
  • MACD
  • SPRC 0.01
  • RELI 0.01
  • Stochastic Oscillator
  • SPRC 91.31
  • RELI 73.20

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: